Free Trial
ASX:OIL

Optiscan Imaging (OIL) Stock Price, News & Analysis

Optiscan Imaging logo

About Optiscan Imaging Stock (ASX:OIL)

Advanced Chart
Remove Ads

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
77,463 shs
Average Volume
N/A
Market Capitalization
$129.48 million
P/E Ratio
N/A
Dividend Yield
4.29%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Optiscan Imaging Limited engages in the development, manufacture, and commercialization of endomicroscopic digital imaging technology solutions for medical, translational, and pre-clinical applications in Australia, Germany, and Internationally. It offers InVivage, an intra-oral digital hand-held confocal endomicroscope for oral cancer screening and/or surgical margin determination; and ViewnVivo, a miniaturized in vivo imaging device that offers single-cell 3D live microscopic imaging. The company has a collaboration agreement with Mayo Clinic to develop a digital confocal laser endomicroscopic imaging system for applications in robotic surgery. Optiscan Imaging Limited was founded in 1994 and is headquartered in Mulgrave, Australia.

Remove Ads
Receive OIL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Optiscan Imaging and its competitors with MarketBeat's FREE daily newsletter.

OIL Stock News Headlines

Trump’s Secret Weapon
Have you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's coming next. But here's the truth… This is just the beginning. Trump has made it clear his tariffs are coming, and that the market will get worse before it gets better. Luckily, our FREE Presidential Transition Guide details exactly what will happen in the next 100 days, and how to protect your hard-earned savings during these times. Don't wait for the next crash to wipe you out. Act now.
Optiscan Imaging Limited Releases Half-Year Report
Optiscan Imaging Limited
See More Headlines

OIL Stock Analysis - Frequently Asked Questions

Optiscan Imaging Limited (ASX:OIL) issued its earnings results on Thursday, February, 28th. The company reported $0.00 earnings per share for the quarter. Optiscan Imaging had a negative trailing twelve-month return on equity of 40.05% and a negative net margin of 230.34%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Optiscan Imaging investors own include Brookside Energy (BRK), (FIRE.V) (FIRE) and Core Lithium (CXO).

Company Calendar

Last Earnings
2/28/2019
Today
3/25/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Industry
Scientific & Technical Instruments
Sub-Industry
Banking
Current Symbol
ASX:OIL
CIK
N/A
Fax
N/A
Employees
2,020
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-6,060,000.00
Net Margins
-230.34%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$2.99 million
Price / Cash Flow
43.00
Book Value
A$0.02 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$129.48 million
Optionable
Not Optionable
Beta
1.20
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (ASX:OIL) was last updated on 3/25/2025 by MarketBeat.com Staff
From Our Partners